Other Events ·
Nasdaq notifies company of non-compliance with the $1.00 minimum bid price requirement
ACTUActuate Therapeutics, Inc.
The Nasdaq Stock Market LLC notified Actuate Therapeutics, Inc. that its common stock closed below the $1.00 per share minimum bid price for 30 consecutive business days. The company has an initial compliance period of 180 calendar days, ending April 26, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 for 10 consecutive business days. Failure to comply may result in delisting or transfer to the Nasdaq Capital Market. This notice is separate from a prior deficiency regarding minimum market value requirements. Actuate Therapeutics operates in the biotechnology industry, focusing on drug discovery and development.